A Study of Adalimumab for the Induction of Clinical Remission in Japanese Subjects With Crohn's Disease

Clinical trial NCT00445939 · COMPLETED

Trial details

NCT number: NCT00445939
Sponsor: Abbott
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Crohn's Disease

Start date: 2007-02-01
Primary completion: 2007-12-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.